- Home
- BEAT vs DMA Comparison
BEAT vs DMA Comparison
Compare BEAT & DMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BEAT
- DMA
- Stock Information
- Founded
- BEAT 2015
- DMA 2011
- Country
- BEAT United States
- DMA United States
- Employees
- BEAT N/A
- DMA N/A
- Industry
- BEAT Retail: Computer Software & Peripheral Equipment
- DMA Trusts Except Educational Religious and Charitable
- Sector
- BEAT Technology
- DMA Finance
- Exchange
- BEAT Nasdaq
- DMA Nasdaq
- Market Cap
- BEAT 74.1M
- DMA 77.0M
- IPO Year
- BEAT 2021
- DMA N/A
- Fundamental
- Price
- BEAT $2.26
- DMA $8.63
- Analyst Decision
- BEAT Buy
- DMA
- Analyst Count
- BEAT 1
- DMA 0
- Target Price
- BEAT $8.00
- DMA N/A
- AVG Volume (30 Days)
- BEAT 110.4K
- DMA 34.6K
- Earning Date
- BEAT 03-19-2025
- DMA 01-01-0001
- Dividend Yield
- BEAT N/A
- DMA 2.04%
- EPS Growth
- BEAT N/A
- DMA N/A
- EPS
- BEAT N/A
- DMA N/A
- Revenue
- BEAT N/A
- DMA N/A
- Revenue This Year
- BEAT N/A
- DMA N/A
- Revenue Next Year
- BEAT N/A
- DMA N/A
- P/E Ratio
- BEAT N/A
- DMA N/A
- Revenue Growth
- BEAT N/A
- DMA N/A
- 52 Week Low
- BEAT $1.35
- DMA $4.78
- 52 Week High
- BEAT $3.48
- DMA $8.00
- Technical
- Relative Strength Index (RSI)
- BEAT 47.78
- DMA 54.10
- Support Level
- BEAT $2.02
- DMA $8.41
- Resistance Level
- BEAT $2.44
- DMA $8.92
- Average True Range (ATR)
- BEAT 0.14
- DMA 0.14
- MACD
- BEAT 0.04
- DMA 0.02
- Stochastic Oscillator
- BEAT 50.00
- DMA 50.88
About BEAT Heartbeam Inc.
HeartBeam Inc is a medical technology company primarily focusing on developing and commercializing higher resolution ambulatory Electrocardiogram ("ECG") solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The Company's ability to develop higher-resolution ECG solutions is achieved through the development of the Company's proprietary and patented Vector Electrocardiography ("VECG") technology platform. The Company has validated this technology and is seeking U.S. Food and Drug Administration ("FDA") clearance for its initial telehealth products.
About DMA Destra Multi-Alternative Fund
Destra Multi-Alternative Fund is a non-diversified, closed-end management investment company that operates as an interval fund with a continuous offering of fund shares. The investment objective of the fund is to seek returns from capital appreciation and income with an emphasis on income generation.